Q3 saw a 6% RevPAR increase and 11% ADR growth year-over-year, with cash up 33% to $2,182 million. Net loss widened, but a robust pipeline and strong segment performance support future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.